Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Aspergillosis and CYP2C19[original query] |
|---|
| Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients. European journal of clinical pharmacology 2011 Mar 67 (3): 253-60. Berge Maud, Guillemain Romain, Trégouet David A, Amrein Catherine, Boussaud Veronique, Chevalier Patrick, Lillo-Lelouet Agnes, Le Beller Christine, Laurent-Puig Pierre, Beaune Philippe H, Billaud Eliane M, Loriot Marie-An |
| Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience. Mycoses 2012 Nov 55 (6): 483-92. Racil Zdenek, Winterova Jana, Kouba Michal, Zak Pavel, Malaskova Ludmila, Buresova Lucie, Toskova Martina, Lengerova Martina, Kocmanova Iva, Weinbergerova Barbora, Timilsina Shira, Rolencova Monika, Cetkovsky Petr, Mayer Ji |
| Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population. Infection & chemotherapy 2013 Dec 45 (4): 406-14. Kim Si-Hyun, Lee Dong-Gun, Kwon Jae-Cheol, Lee Hyo-Jin, Cho Sung-Yeon, Park Chulmin, Kwon Eun-Young, Park Sun Hee, Choi Su-Mi, Choi Jung-Hyun, Yoo Jin-Ho |
| Invasive aspergillosis in a paediatric allogeneic stem cell transplantation recipient owing to a susceptible Aspergillus fumigatus: Treatment failure with high doses of voriconazole and influence of CYP2C19 polymorphisms. International journal of antimicrobial agents 2016 Feb . Cendejas-Bueno Emilio, Borobia Alberto M, Gomez-Lopez Alicia, Escosa-García Luis, Río-García Miguel, Plaza Diego, García-Rodriguez Julio, Carcas-Sansuán Anton |
| Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole. Current fungal infection reports 2015 Jun 9 (2): 74-87. Moriyama Brad, Kadri Sameer, Henning Stacey A, Danner Robert L, Walsh Thomas J, Penzak Scott |
| A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis. Drug metabolism and pharmacokinetics 2016 Jan . Sumonrat Chuwongwattana, Jantararoungtong Thawinee, Chitasombat Maria N, Puangpetch Apichaya, Prommas Santirat, Dilokpattanamongkol Pitchaya, Watcharananan Siriorn P, Sukasem Chonlaph |
| Impact of CYP2C19 Polymorphisms on Serum Concentration of Voriconazole in Iranian Hematological Patients. Journal of research in pharmacy practice 0 6 (3): 151-157. Ebrahimpour Sholeh, Namazi Soha, Mohammadi Mehdi, Nikbakht Mohsen, Hadjibabaie Molouk, Masoumi Hamidreza Taghvaye, Ghavamzadeh Ardesh |
| Frequency of the CYP2C19*17 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children. Scientific reports 2019 Jun 9 (1): 8863. Espinoza N, Galdames J, Navea D, Farfán M J, Salas |
| High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness. Antimicrobial agents and chemotherapy 2019 3 63 (6): . Bernal-Martínez L, Alcazar Fuoli L, Miguel-Revilla B, Carvalho A, Cuétara Garcia M S, Garcia-Rodriguez J, Cunha C, Gómez-García de la Pedrosa E, Gomez-Lopez |
| Voriconazole-induced Severe Hyperkalemia Precipitated by Multiple Drug Interactions. Electrolyte & blood pressure : E & BP 2020 7 18 (1): 10-15. Choi Jae Young, Cho Seong Geun, Jang Ki-Seok, Kim Gheun- |
| Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report. Infection and drug resistance 2023 8 16 5405-5411. Li Gu, Tao Ai, Ling Pang, Dong Xu, Han Wa |
| Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole. Clinical and translational science 2024 7 17 (7): e13887. Sylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, Mark G J de Boer, Lambert F R Span, Henk-Jan Guchelaar, Jesse J Sw |
| Case report: dose-dependent interaction between dexamethasone and voriconazole in severely ill patients with non-Hodgkin's lymphoma being treated for invasive pulmonary aspergillosis. Frontiers in pharmacology 2024 7 15 1403966. Jingjing Huang, Yang Chen, Ming Zhong, Ruoming T |
| Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects. Journal of clinical pharmacology 2024 4 . Shuaibing Liu, Xia Yao, Jun Tao, Shiyu Zhao, Suke Sun, Suyun Wang, Xin Ti |
- Page last reviewed:Feb 1, 2024
- Content source: